These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Treatment of juvenile diabetics with highly purified insulin preparations--effect on the formation insulin antibodies and metabolic compensation]. Michalková D; Bircák J; Cársky J; Kolár J; Sílesová J; Zmeková-Jancová E Cesk Pediatr; 1985 Apr; 40(4):219-23. PubMed ID: 3893762 [No Abstract] [Full Text] [Related]
4. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes. Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584 [TBL] [Abstract][Full Text] [Related]
5. Relationship of glycosylated haemoglobin to C-peptide secretory status and antibody binding of insulin in insulin-dependent diabetes. Gray RS; Borsey DQ; Kurtz A; Rainbow S; Smith AF; Elton RA; Duncan LJ; Clarke BF Horm Metab Res; 1981 Nov; 13(11):599-603. PubMed ID: 7030898 [TBL] [Abstract][Full Text] [Related]
6. Insulin antibodies in juvenile diabetes mellitus. Correlations to diabetic stability, insulin requirement and duration of insulin treatment. Keilacker H; Rjasanowski I; Ziegler M; Michaelis D; Woltanski KP; Besch W Horm Metab Res; 1982 May; 14(5):227-32. PubMed ID: 7047344 [TBL] [Abstract][Full Text] [Related]
7. The role of insulin antibodies in insulin treatment of type I diabetes. Keilacker H; Rjasanowski I; Ziegler M; Michaelis D; Woltanski KP; Besch W Exp Clin Endocrinol; 1986 Jun; 87(1):79-88. PubMed ID: 3527726 [TBL] [Abstract][Full Text] [Related]
8. Effect of anti-insulin antibodies on glycemic control in insulin treated diabetic patients. Sakata S; Matsuda M; Komaki T; Miura K Immunol Invest; 1986 Dec; 15(8):791-9. PubMed ID: 3298026 [TBL] [Abstract][Full Text] [Related]
9. Correlation between HbA1c, purified insulins, diabetic control, and insulin antibodies in diabetic children. Bistritzer T; Sack J; Theodor R; Weissglass L; Ben-Bassat I; Lahav M Horm Res; 1984; 20(3):178-85. PubMed ID: 6386647 [TBL] [Abstract][Full Text] [Related]
10. Relationship between insulin antibodies and metabolic control in type I diabetes mellitus. Moisés RS; Sá JR; Chacra AR; Russo EM Braz J Med Biol Res; 1990; 23(12):1243-52. PubMed ID: 2136556 [TBL] [Abstract][Full Text] [Related]
11. The influence of insulin antibodies on the pharmacokinetics of NPH insulin in patients with type 1 diabetes treated with human insulin. Peters A; Klose O; Hefty R; Keck F; Kerner W Diabet Med; 1995 Oct; 12(10):925-30. PubMed ID: 8846686 [TBL] [Abstract][Full Text] [Related]
12. Studies on juvenile--type diabetes in children. Assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides. Schatz H; Winkler G; Jonatha EM; Pfeiffer EF Diabete Metab; 1975 Dec; 1(4):211-20. PubMed ID: 1234581 [TBL] [Abstract][Full Text] [Related]
13. Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects. Fireman P; Fineberg SE; Galloway JA Diabetes Care; 1982; 5 Suppl 2():119-25. PubMed ID: 6765521 [TBL] [Abstract][Full Text] [Related]
14. Insulin antibody response to a short course of human insulin therapy in women with gestational diabetes. Balsells M; Corcoy R; Mauricio D; Morales J; García-Patterson A; Carreras G; Puig-Domingo M; de Leiva A Diabetes Care; 1997 Jul; 20(7):1172-5. PubMed ID: 9203458 [TBL] [Abstract][Full Text] [Related]
15. Association of morning fasting blood glucose variability with insulin antibodies and clinical factors in type 1 diabetes. Yoneda C; Tashima-Horie K; Fukushima S; Saito S; Tanaka S; Haruki T; Ogino J; Suzuki Y; Hashimoto N Endocr J; 2016 Jul; 63(7):603-9. PubMed ID: 27170092 [TBL] [Abstract][Full Text] [Related]
16. Associations of insulin-induced lipodystrophy in children, adolescents, and young adults with type 1 diabetes mellitus using recombinant human insulin: a cross-sectional study. Singha A; Bhattacharjee R; Dalal BS; Biswas D; Choudhuri S; Chowdhury S J Pediatr Endocrinol Metab; 2021 Apr; 34(4):503-508. PubMed ID: 33662195 [TBL] [Abstract][Full Text] [Related]
17. [Severe hypoglycemia and insulin antibodies levels in children and adolescents with type 1 diabetes]. Mianowska B; Perenc M; Heinrich A; Bodalski J Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):29-34. PubMed ID: 12831635 [TBL] [Abstract][Full Text] [Related]
18. Jet-injected insulin is associated with decreased antibody production and postprandial glucose variability when compared with needle-injected insulin in gestational diabetic women. Jovanovic-Peterson L; Sparks S; Palmer JP; Peterson CM Diabetes Care; 1993 Nov; 16(11):1479-84. PubMed ID: 8299437 [TBL] [Abstract][Full Text] [Related]
19. The effect of insulin antibodies on insulin dose and diabetic control. Walford S; Allison SP; Reeves WG Diabetologia; 1982 Feb; 22(2):106-10. PubMed ID: 7037511 [TBL] [Abstract][Full Text] [Related]
20. Insulin antibodies and hypoglycemia in diabetic patients. Can a quantitative analysis of antibody binding predict the risk of hypoglycemia? Kim MR; Sheeler LR; Mansharamani N; Haug MT; Faiman C; Gupta MK Endocrine; 1997 Jun; 6(3):285-91. PubMed ID: 9368685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]